| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US1472496P | 1996-03-21 | 1996-03-21 | |
| CA002248136ACA2248136A1 (en) | 1996-03-21 | 1996-03-21 | Human endometrial specific steroid-binding factor i, ii and iii | 
| PCT/US1996/003857WO1997034997A1 (en) | 1996-03-21 | 1996-03-21 | Human endometrial specific steroid-binding factor i, ii and iii | 
| US08/821,451US6066724A (en) | 1996-03-21 | 1997-03-21 | Human endometrial specific steroid-binding factor I, II and III | 
| Publication Number | Publication Date | 
|---|---|
| EP0896614A1 EP0896614A1 (en) | 1999-02-17 | 
| EP0896614A4true EP0896614A4 (en) | 1999-05-12 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| EP96910504AWithdrawnEP0896614A4 (en) | 1996-03-21 | 1996-03-21 | Human endometrial specific steroid-binding factor i, ii and iii | 
| Country | Link | 
|---|---|
| EP (1) | EP0896614A4 (en) | 
| AU (1) | AU5367996A (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO1996038463A1 (en)* | 1995-05-31 | 1996-12-05 | Washington University | Dna sequence and encoded mammary-specific breast cancer protein | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO1996038463A1 (en)* | 1995-05-31 | 1996-12-05 | Washington University | Dna sequence and encoded mammary-specific breast cancer protein | 
| Title | 
|---|
| See also references ofWO9734997A1* | 
| WATSON M.A. ET AL.: "Mammaglobin, a mammary-specific member of the Uteroglobin gene family, is overexpressed in human breast cancer", CANCER RESEARCH, vol. 56, 15 February 1996 (1996-02-15), pages 860 - 865, XP002048615* | 
| Publication number | Publication date | 
|---|---|
| EP0896614A1 (en) | 1999-02-17 | 
| AU5367996A (en) | 1997-10-10 | 
| Publication | Publication Date | Title | 
|---|---|---|
| HRP970680B1 (en) | New ketobenzamides and their use | |
| GB2316102B (en) | Truss | |
| PL328822A1 (en) | Human bikinine | |
| IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
| AU132263S (en) | Chair | |
| IL120016A0 (en) | Heteroatom-containing cyclopentanopyridyl-oxazolidinones their preparation and use | |
| ZA975591B (en) | New amidino derivatives and their use as thrombininhibitors | |
| SI1019358T1 (en) | 3,3-diarylpropylamines , their use and preparation | |
| AU130799S (en) | Chair | |
| PL331523A1 (en) | Azolotrizines and azolopyrimidines | |
| AU5557698A (en) | Novel calpaines, their preparation and use | |
| AU3116697A (en) | Human interleukin-1j and antagonists thereof | |
| GB9621990D0 (en) | Use | |
| EP0896614A4 (en) | Human endometrial specific steroid-binding factor i, ii and iii | |
| GB9611192D0 (en) | Use | |
| ZA9710857B (en) | Novel calpains their preparation and use | |
| PL332044A1 (en) | 25-methylene and 24,25-epoxy marcphortines and paraherquamides | |
| CA78068S (en) | Chair | |
| CA79215S (en) | Chair | |
| CA78172S (en) | Chair | |
| CA78403S (en) | Chair | |
| CA78402S (en) | Chair | |
| CA78069S (en) | Chair | |
| CA78070S (en) | Chair | |
| CA78401S (en) | Chair | 
| Date | Code | Title | Description | 
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:19981021 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE | |
| A4 | Supplementary search report drawn up and despatched | Effective date:19990326 | |
| AK | Designated contracting states | Kind code of ref document:A4 Designated state(s):AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE | |
| 17Q | First examination report despatched | Effective date:20020423 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION HAS BEEN WITHDRAWN | |
| 18W | Application withdrawn | Effective date:20050705 |